Novavax Inc (NVAX)
4.51
+0.04
(+0.89%)
USD |
NASDAQ |
May 09, 15:08
Novavax Net Income (TTM): -545.06M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -545.06M |
| September 30, 2023 | -548.92M |
| June 30, 2023 | -586.76M |
| March 31, 2023 | -1.155B |
| December 31, 2022 | -657.94M |
| September 30, 2022 | -1.322B |
| June 30, 2022 | -1.476B |
| March 31, 2022 | -1.318B |
| December 31, 2021 | -1.744B |
| September 30, 2021 | -1.075B |
| June 30, 2021 | -949.91M |
| March 31, 2021 | -615.11M |
| December 31, 2020 | -418.26M |
| September 30, 2020 | -272.52M |
| June 30, 2020 | -93.26M |
| March 31, 2020 | -115.34M |
| December 31, 2019 | -132.69M |
| September 30, 2019 | -150.20M |
| June 30, 2019 | -176.72M |
| March 31, 2019 | -181.61M |
| December 31, 2018 | -184.75M |
| September 30, 2018 | -186.26M |
| June 30, 2018 | -186.29M |
| March 31, 2018 | -186.27M |
| December 31, 2017 | -183.77M |
| Date | Value |
|---|---|
| September 30, 2017 | -190.04M |
| June 30, 2017 | -211.68M |
| March 31, 2017 | -246.57M |
| December 31, 2016 | -279.97M |
| September 30, 2016 | -301.66M |
| June 30, 2016 | -268.53M |
| March 31, 2016 | -209.82M |
| December 31, 2015 | -156.94M |
| September 30, 2015 | -109.68M |
| June 30, 2015 | -96.28M |
| March 31, 2015 | -93.51M |
| December 31, 2014 | -82.95M |
| September 30, 2014 | -65.46M |
| June 30, 2014 | -61.03M |
| March 31, 2014 | -55.80M |
| December 31, 2013 | -51.98M |
| September 30, 2013 | -45.96M |
| June 30, 2013 | -37.88M |
| March 31, 2013 | -31.17M |
| December 31, 2012 | -28.51M |
| September 30, 2012 | -24.18M |
| June 30, 2012 | -20.17M |
| March 31, 2012 | -19.25M |
| December 31, 2011 | -19.36M |
| September 30, 2011 | -21.94M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-1.744B
Minimum
Dec 2021
-93.26M
Maximum
Jun 2020
-702.74M
Average
-586.76M
Median
Jun 2023
Net Income (TTM) Benchmarks
| Pfizer Inc | -309.00M |
| Moderna Inc | -5.968B |
| Agilent Technologies Inc | 1.236B |
| Halozyme Therapeutics Inc | 281.59M |
| Vaxart Inc | -82.46M |